Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChenavari Toro Regulatory News (TORO)

Share Price Information for Chenavari Toro (TORO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.512
Bid: 0.494
Ask: 0.53
Change: -0.018 (-3.40%)
Spread: 0.036 (7.287%)
Open: 0.512
High: 0.512
Low: 0.512
Prev. Close: 0.53
TORO Live PriceLast checked at -
Chenavari Toro Income is an Investment Trust

To deliver an absolute return primarily investing and trading in ABS and other structured credit investments in liquid markets, and investing in asset backed transactions including through the origination of credit portfolios.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enhanced dividend policy - rebalancing of strategy

8 Jun 2020 07:00

RNS Number : 1781P
Chenavari Toro Income Fund Limited
08 June 2020
 

Chenavari Toro Income Fund Limited (the Company)

08 JUNE 2020

Enhanced dividend policy and rebalancing of investment strategy

 

In the past few years, the Board of the Company has implemented several measures to seek to enhance the share price of the Company, in particular by reducing the discount between the Company's share price and the net asset value per share ("NAV per Share"). These measures have included undertaking share buy-backs, the implementation of a semi-annual tender offer mechanism, and a simplification of the Company's investment strategy.

While the Board acknowledges that the Company's net asset value ("NAV") has held up more robustly than most of the Company's listed peers in the recent major market dislocation arising from the global COVID-19 pandemic, it also acknowledges the disappointment caused to shareholders by the persistent share price discount to NAV.

The Board is therefore pleased to announce the implementation of a series of new initiatives with the intention of narrowing the share price discount to NAV. These initiatives are as follows:

1. An enhanced dividend policy: The Company is targeting a quarterly dividend yield of 2.5 per cent. (by reference to NAV) equating to a targeted annualised dividend yield of 10 per cent. (by reference to NAV). The Company's net target return remains 9-11 per cent. per annum

The dividend and net target return targets stated above are targets only and are not a profit forecast. There can be no assurance that these targets will be met and they should not be taken as an indication of the Company's expected future results.

2. The continued rebalancing of the investment strategy towards tradable securities, as well as the realisation of illiquid assets: Operating within the parameters of the Company's existing investment policy, the Company's investment strategy will be rebalanced with a focus on investment in liquid and tradable European ABS/CLO, through the Company's existing "opportunistic credit strategy" (provided that a significant market opportunity arises). Consequently, the Company will cease to make new investments in illiquid assets through its current "originated transactions" and "private asset backed" strategies, but will continue to support existing illiquid assets, where required, with a view to maximising shareholder value. The Company will seek to realise its illiquid assets and redeploy the proceeds into liquid and tradable European ABS/CLO if the opportunity arises. In addition to this rebalancing of the investment strategy, the Company will continue to consider share buy-backs, where appropriate, to assist in narrowing the discount to NAV, and will continue to invest in hedging instruments.

3. The implementation of quarterly special distributions of available excess cash: at the end of each calendar quarter until 31 December 2020, the Company will maintain a maximum cash balance in its portfolio of 10 per cent. of NAV and will distribute all excess cash above this balance arising in the portfolio as special dividends on a quarterly basis. These special dividends will be in addition to any quarterly dividends paid pursuant to the Company's dividend policy outlined above. With effect from 1 January 2021, the maximum cash balance cap will be reduced to a level of not more than 5 per cent. of NAV, unless the investment manager, at its discretion, decides to maintain such cap at a maximum of 10 per cent., should market opportunities in liquid and tradable European ABS / CLO arise.

The payment of any quarterly special dividends is a target only and will be subject to the Company having excess cash available to do. Shareholders should have no expectation of any such quarterly special dividends being paid in any quarter or at all.

 

Fred Hervouet, Chairman of the Board, commented:

"The persistence of the discount to NAV has somewhat overshadowed the underlying quality of the Company. We hope that the announcement of these new initiatives will provide assurance to shareholders that the Company will do whatever it takes to seek to narrow and eventually eliminate the discount. Through these new steps, we are demonstrating the Board's commitments to seek to; (i) generate a high investment return profile for shareholders, and (ii) maximize shareholder value".

 

Further information in relation to the Company is available at:

http://www.chenavaritoroincomefund.com

 

Enquiries:

Kirstie Sumarno or Guy Goyard

Chenavari Investment Managers

Email: tlir@chenavari.com

Telephone: +44 20 7259 3600

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFAMPTMTBMBIM
Date   Source Headline
1st May 20247:00 amRNSCompany Factsheet Available
30th Apr 20247:00 amRNSDividend Declaration
29th Apr 20245:00 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20245:00 pmRNSCompany Factsheet Available
27th Mar 20245:00 pmRNSNet Asset Value(s)
8th Mar 20241:00 pmRNSResult of AGM
7th Mar 20245:00 pmRNSShares in Issue
29th Feb 20247:00 amRNSCompany Factsheet Available
26th Feb 20245:00 pmRNSNet Asset Value(s)
15th Feb 20245:00 pmRNSScrip Dividend Election Price
8th Feb 20247:00 amRNSNotice of AGM
31st Jan 20247:00 amRNSCompany Factsheet Available
30th Jan 20247:01 amRNSQuarterly Investor Webinar
30th Jan 20247:00 amRNSDividend Declaration
25th Jan 20247:00 amRNSNet Asset Value(s)
5th Jan 20247:00 amRNSCompany Factsheet Available
2nd Jan 20247:00 amRNSTotal Voting Rights
28th Dec 20237:00 amRNSAnnual Report and Audited Financial Statements
22nd Dec 20237:01 amRNSShares in Issue
18th Dec 20237:00 amRNSNet Asset Value(s)
8th Dec 20235:00 pmRNSShares in Issue
29th Nov 20237:00 amRNSCompany Factsheet Available
22nd Nov 202310:30 amRNSNet Asset Value(s)
16th Nov 20235:00 pmRNSScrip Dividend Election Price
3rd Nov 20237:05 amRNSQuarterly Investor Webinar
27th Oct 20235:00 pmRNSCompany Factsheet Available
27th Oct 20237:00 amRNSDividend Declaration
26th Oct 20237:00 amRNSNet Asset Value(s)
2nd Oct 20237:00 amRNSTotal Voting Rights
29th Sep 20237:00 amRNSCompany Factsheet Available
21st Sep 20235:00 pmRNSNet Asset Value(s)
8th Sep 20235:00 pmRNSShares in Issue
29th Aug 20237:00 amRNSCompany Factsheet Available
21st Aug 20235:00 pmRNSNet Asset Value(s)
17th Aug 20235:00 pmRNSScrip Dividend Election Price
28th Jul 20237:00 amRNSDividend Declaration
27th Jul 20237:00 amRNSCompany Factsheet Available
21st Jul 20237:00 amRNSNet Asset Value(s)
3rd Jul 20237:00 amRNSTotal Voting Rights
30th Jun 20237:00 amRNSCompany Factsheet Available
28th Jun 20235:00 pmRNSInterim Financial Statements
22nd Jun 202311:00 amRNSNet Asset Value(s)
9th Jun 20235:00 pmRNSShares in Issue
1st Jun 20237:00 amRNSCompany Factsheet Available
23rd May 20235:45 pmRNSNet Asset Value(s)
18th May 20235:00 pmRNSScrip Dividend Election Price
28th Apr 20235:00 pmRNSCompany Factsheet Available
28th Apr 20237:01 amRNSDirectorate Change
28th Apr 20237:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.